期刊文献+

肠道病毒71型全病毒灭活疫苗(C4亚型)的交叉中和特性 被引量:1

Cross-neutralizing characteristic of inactivated enterovirus 71 whole virus vaccine(subgenotype C4)
原文传递
导出
摘要 目的评价肠道病毒71型(enterovirus 71,EV71)全病毒灭活疫苗(C4亚型)的交叉中和特性。方法采用微量细胞病变法检测我国EV71全病毒灭活疫苗(C4亚型)免疫血清(46份)对B0~B4、C1、C2、C4和C5亚型的中和效价,计算几何平均滴度(geometric mean titer,GMT)及其增长倍数(fold increase in geometric mean titer,GMFI),并评价B0~B4、C1、C2、C5亚型与C4亚型检测结果的相关性(R^(2))。结果46份免疫血清的各亚型EV71中和抗体阳转率均为100%,GMTs范围为288.9~871.3,GMFIs为72.2~217.8。B0~B4、C1、C2和C5亚型与C4亚型检测结果呈正相关,R^(2)分别为0.6528、0.6184、0.6391、0.7195、0.6891、0.6693、0.7264和0.6974。结论我国EV71全病毒灭活疫苗(C4亚型)对B0~B4、C1、C2和C5亚型EV71具有良好的交叉中和活性。 Objective To evaluate the cross neutralizing characteristics of inactivated enterovirus 71(EV71)vaccine(subgenotype C4).Methods The neutralizing titers of 46 serum samples immunized with inactivated EV71 vaccine(subgenotype C4)against EV71 strains of subgenotypes B0~B4,C1,C2,C4 and C5 were determined by microcytopathic method,based on which the geometric mean titer(GMT)and fold increase in geometric mean titer(GMFI)were calculated,and the relationships of determination results of subgenotypes B0~B4,C1,C2,C5 to that of subgenotype C4 were evaluated(R^(2)).Results All the positive rates of neutralizing antibodies against EV71 of various subgenotypes in46 serum samples were 100%,while the GMTs were 288.9~871.3,and the GMFIs were 72.2~217.8.The determination results of subgenotypes B0~B4,C1,C2 and C5 were positively to that of subgenotype C4,with R^(2) values of 0.6528,0.6184,0.6391,0.7195,0.6891,0.6693,0.7264 and 0.6974 respectively.Conclusion Inactivated EV71 vaccine(subgenotype C4)showed good cross neutralizing activity to subgenotypes B0~B4,C1,C2 and C5.
作者 刘佩 卞莲莲 霍雅倩 陈磊 刘思远 毛群颖 吴星 高帆 梁争论 LIU Pei;BIAN Lian-lian;HUO Ya-qian;CHEN Lei;LIU Si-yuan;MAO Qun-ying;WU Xing;GAO Fan;LIANG Zheng-lun(National Institute for Food and Drug Control,Beijing 102629,China)
出处 《中国生物制品学杂志》 CAS CSCD 北大核心 2021年第6期633-636,642,共5页 Chinese Journal of Biologicals
基金 “十三五”科技重大专项(2018ZX09737-011)。
关键词 肠道病毒71型 C4亚型 灭活疫苗 交叉中和 Enterovirus 71(EV71) C4 subtypes Inactivated vaccine Cross-neutralization
  • 相关文献

参考文献2

二级参考文献39

  • 1中国疾病预防控制中心.法定传染病报告[R/OL].(2014.01-xx)[2014-08.05].http://www.chinacdc.cnltjsj/fdcrbbg/. 被引量:1
  • 2Solomon T, Lewthwaite P, Perera D, et cd. Virology, epide- miology, pathogenesis, and control of enterovirus 71 [J]. Lan- cet Infect Dis, 2010, 10 (11): 778-790. 被引量:1
  • 3Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71 [J]. Lancet Ne- urol, 2010, 9 (ll): 1097-1105. 被引量:1
  • 4Huang YP, Lin TL, Hsu LC, et al. Genetic diversity and C2- like subgenogroup strains of enterovirus 71, Taiwan, 2008 [J]. Viro| J, 2010, 7 (1): 277-287. 被引量:1
  • 5Kung YA, Hung CT, Liu YC, et 01. Update on the develop- ment of enterovirus 71 vaccines [J]. Expert Opin Biol Ther, 2014, 14 (10): 1455-1464. 被引量:1
  • 6Hwa SH, Lee YA, Brewoo JN, et 01. Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine [J]. PLoS Negl Trop Dis, 2013, 7 (11): e2538. 被引量:1
  • 7Chou AH, Liu CC, Chang JY, et ol. Immunological evaluation and comparison of different EV71 vaccine candidates [J]. Clin Dev Immunol, 2012, 2012(9): 831282-831289. 被引量:1
  • 8Zhu F, Xu W, Xia J, et ol. Efficacy, safety, and immuno- genicity of an enterovirus 71 vaccine in China [J]. N Engl J Med, 2014, 370 (9): 818-828. 被引量:1
  • 9Li R, Liu L, Mo Z, et 01. An inactivated enterovirus 71 vac- cine in healthy children [J]. N Engl J Med, 2014, 370 (9): 829-837. 被引量:1
  • 10Zhu FC, Meng FY, Li JX, et 01. Efficacy, safety, and immu-nology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial [J]. Lancet, 2013, 381 (9882): 2024-2032. 被引量:1

共引文献17

同被引文献42

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部